Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1330 issues

Work With Your Doctor to Get Mepsevii (Vestronidase Alfa) Approved by Blue Cross Blue Shield in Michigan: Complete Provider Collaboration Guide

Answer Box: Getting Mepsevii Approved in Michigan Blue Cross Blue Shield Michigan requires prior authorization for Mepsevii (vestronidase alfa-vjbk) with confirmed MPS VII diagnosis and specialist involvement. Success depends on close collaboration with your prescribing doctor to submit comprehensive documentation through the NovoLogix portal. Fastest path: 1) Gather genetic/enzyme

How to Get Mavenclad (Cladribine Tablets) Covered by Blue Cross Blue Shield of Illinois: Requirements, Forms & Appeal Process

Answer Box: Getting Mavenclad Covered by BCBS Illinois Yes, Blue Cross Blue Shield of Illinois covers Mavenclad (cladribine tablets) with prior authorization. The fastest path: (1) Verify your plan requires PA through Availity Essentials, (2) Submit complete clinical documentation showing relapsing MS diagnosis (ICD-10: G35.A or G35.C1) and

Blue Cross Blue Shield California Coverage for Acthar Gel: Medical Necessity Criteria, Prior Authorization, and Appeals Guide

Answer Box: Getting Acthar Gel Covered in California Blue Cross Blue Shield California requires prior authorization for Acthar Gel with documented failure of corticosteroids first. The fastest path: Have your doctor submit a PA request through the provider portal with complete clinical notes showing corticosteroid trial failure or contraindications. If

How to Get Juxtapid (Lomitapide) Covered by Blue Cross Blue Shield in Georgia: Complete Requirements Checklist

Answer Box: Getting Juxtapid Covered by BCBS Georgia Blue Cross Blue Shield in Georgia requires prior authorization for Juxtapid (lomitapide) with strict criteria focused on homozygous familial hypercholesterolemia (HoFH) diagnosis and safety monitoring. Success depends on three key elements: (1) genetic or clinical documentation of HoFH, (2) proof of failed

How to Get Lutathera (Lutetium Lu-177 Dotatate) Covered by Blue Cross Blue Shield in Pennsylvania: Complete Provider Collaboration Guide

Answer Box: Getting Lutathera Covered by Blue Cross Blue Shield in Pennsylvania Blue Cross Blue Shield plans in Pennsylvania (Highmark, Independence Blue Cross) require prior authorization for Lutathera (lutetium Lu-177 dotatate) with strict clinical criteria. Fastest approval path: Confirm you have GEP-NET diagnosis with SSTR-positive imaging, documented octreotide/lanreotide failure,

Work With Your Doctor to Get Adynovate Approved by Blue Cross Blue Shield in Georgia: Forms, Appeals, and Medical Necessity Templates

Answer Box: Getting Adynovate Approved in Georgia Blue Cross Blue Shield of Georgia requires prior authorization for Adynovate under clinical criteria CC-0149. To get approved: 1) Work with your hematologist to document severe hemophilia A diagnosis and bleeding history, 2) Submit prior authorization through Anthem's provider portal with

How to Get Oxervate (Cenegermin) Covered by Blue Cross Blue Shield in Pennsylvania: Complete Coverage Guide

Quick Answer: Getting Oxervate Covered by Blue Cross Blue Shield in Pennsylvania Oxervate (cenegermin) requires prior authorization from Pennsylvania Blue Cross Blue Shield plans. Your fastest path to approval: (1) Confirm stage 2 or 3 neurotrophic keratitis diagnosis with corneal sensitivity testing, (2) document 14+ days of failed preservative-free artificial

How to Get Amvuttra (vutrisiran) Covered by Horizon Blue Cross Blue Shield in New Jersey: Complete Prior Authorization Guide

Answer Box: Getting Amvuttra Covered in New Jersey Amvuttra (vutrisiran) requires prior authorization from Horizon Blue Cross Blue Shield of New Jersey and is subject to step therapy requirements. Most patients must first try and fail patisiran (Onpattro) or tafamidis before approval. Here's your fastest path: 1. Gather

How to Get Kymriah (tisagenlecleucel) Covered by Blue Cross Blue Shield in Virginia: Decision Tree, Appeals, and Next Steps

Answer Box: Getting Kymriah Coverage in Virginia Kymriah (tisagenlecleucel) requires prior authorization from all Blue Cross Blue Shield plans in Virginia as of July 2024. Your fastest path to approval: (1) Confirm treatment at a BCBS-certified CAR-T center, (2) Have your oncologist submit comprehensive clinical documentation through Anthem's

How to Get Vanflyta (quizartinib) Covered by Blue Cross Blue Shield of Illinois: Complete PA Guide and Appeal Process

Answer Box: Getting Vanflyta Covered in Illinois Vanflyta (quizartinib) requires prior authorization from Blue Cross Blue Shield of Illinois for FLT3-ITD positive AML. Submit the Illinois Uniform Prior Authorization Form with FLT3-ITD mutation testing, cardiac monitoring plan, and REMS enrollment documentation. If denied, you have 180 days for internal appeal